|
Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2021 Earnings Release and Conference Call for March 1, 2022, at 4:30 p.m. Eastern Time
02/15/2022
|
|
|
Ascensia Diabetes Care Announces Fda Approval Of The Eversense E3 Continuous Glucose Monitoring System For Use For Up To Six Months
02/14/2022
|
|
|
Senseonics Announces FDA Approval of the Eversense® E3 Continuous Glucose Monitoring System for Use for Up to 6 months; Provides 2022 Business Outlook
02/11/2022
|
|
|
Senseonics Announces Equity Grants To Employees Under Inducement Plan
01/05/2022
|
|
|
Senseonics Announces Business Updates
01/04/2022
|
|